International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
1,629,659
Fulltext
1,110,899
PDF
518,760

Articles	Fulltext downloads	PDF downloads	Total downloads
Short Communication Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	33,526	3,575	37,101
Review Article Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023	28,159	2,327	30,486
Editorial Challenging conventional wisdom in molecular oncology: New perspectives Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023	26,712	2,195	28,907
Original Article Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023	26,505	2,180	28,685
Case Report *Long-term efficacy of osimertinib in de novo* exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India** Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023	23,993	2,171	26,164
Short Communication Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	21,732	2,843	24,575
Review Article Molecular oncology and the role of artificial intelligence in advancing cancer treatment Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023	22,653	1,630	24,283
Editorial Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024	17,664	2,477	20,141
Review Article Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024	17,779	2,245	20,024
Original Article Spectrum of lymphomas in India Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023	17,139	1,556	18,695
Review Article Understanding immunotherapy and CAR-T-cells: A narrative review Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023	16,522	1,927	18,449
Review Article High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024	16,404	2,011	18,415
News Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	15,786	2,517	18,303
Review Article Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	13,304	4,711	18,015
Case Report Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	12,448	5,408	17,856
Case Report Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023	14,738	2,124	16,862
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	14,206	2,102	16,308
Review Article Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022	14,229	1,961	16,190
Cardio Oncology with ACOS Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	12,090	4,074	16,164
New Drug Update Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	14,033	2,030	16,063
Review Article Combination of PARPi and anti-PD-L1 therapies in ovarian cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022	14,704	1,208	15,912
Review Article Potential therapeutic molecular targets for better outcomes for patients with lung cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022	14,818	950	15,768
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	12,172	3,285	15,457
Original Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	11,302	4,111	15,413
Review Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	10,788	4,350	15,138
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	10,667	4,161	14,828
Case Series Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	12,296	2,341	14,637
Review Article Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	9,207	5,103	14,310
Case Report L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023	12,780	1,362	14,142
Review Article The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	11,724	2,377	14,101
Review Article Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	10,729	3,176	13,905
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	11,166	2,530	13,696
Case Report Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	10,984	2,638	13,622
Editorial Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	6,577	7,008	13,585
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	9,371	4,197	13,568
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	9,998	3,438	13,436
Case Report Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	8,558	4,871	13,429
Conference Review 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	11,253	1,874	13,127
Case Report Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	11,079	2,041	13,120
Brief Commentary ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	10,607	2,486	13,093
Erratum Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	11,504	1,438	12,942
Review Article The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	9,916	2,988	12,904
Brief Commentary Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	10,110	2,500	12,610
Letter to editor Letter to editor Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022	8,255	4,173	12,428
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	8,599	3,810	12,409
Review Article Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	7,851	4,548	12,399
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	6,954	5,397	12,351
Case Report Metastatic endometrial carcinoma responsive to pembrolizumab Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020	7,137	5,212	12,349
Review Article *Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ* hybridization and Immunohistochemistry: A meta-analysis with systematic review** Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019	6,371	5,757	12,128
Original Article Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_1_2019	5,609	5,981	11,590

Most Viewed Articles

Driver mutations in oncogenesis

Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes

Challenging conventional wisdom in molecular oncology: New perspectives

Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India

Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Molecular oncology and the role of artificial intelligence in advancing cancer treatment

Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer

Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article

Spectrum of lymphomas in India

Understanding immunotherapy and CAR-T-cells: A narrative review

High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective

Editorial board tribute to Dr. Amit Verma

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Combination of PARPi and anti-PD-L1 therapies in ovarian cancer

Potential therapeutic molecular targets for better outcomes for patients with lung cancer

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Immune dynamics of SARS-CoV-2 virus evolution

Advances in immunotherapy for metastatic esophageal cancer

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Immuno-oncological era of breast cancer: A progressive path to better treatment

L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

Immuno-oncology of differentiated thyroid cancer

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

Nanobytes

Breast cancer prognostic tools: A promising Indian option

A compendium of population wide DNA methylation profile for oral cancer in India

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

The Cancer Genomic Atlas – “TO CONQUER CANCER”

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

Letter to editor

Molecular genetics changes in gallbladder carcinoma

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

Metastatic endometrial carcinoma responsive to pembrolizumab

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India

**Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India**

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

**Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review**